Missed the Gilead Surge? Here’s What You Need to Know About the Big Move
In late June, Gilead Sciences (GILD) stock surged following positive results of a late-stage trial for its latest HIV drug. ...
Read moreIn late June, Gilead Sciences (GILD) stock surged following positive results of a late-stage trial for its latest HIV drug. ...
Read moreAfter a big run this year, Nvidia (NVDA) fell over 15% from its high and broke its 50-day SMA. On...
Read moreThis will be one of the most interesting quarters in recent memory. The Fed has got to choose its poison....
Read moreFlying Financials In the recent sector rotation, basically OUT of technology and INTO anything else, Financials and Real-Estate led the...
Read moreMajor equity indexes rose on Friday after a selloff that hit the Technology sector especially hard. But this doesn’t necessarily...
Read moreThis week saw the major equity averages continue a confirmed pullback phase, with some of the biggest gainers in the...
Read moreThis week we have four Magnificent Seven stocks reporting earnings. We also take a look at McDonalds (MCD) and Ford...
Read moreGood morning and welcome to this week's Flight Path. Equities had another tough week last week and we saw an...
Read moreDropcap the popularization of the “ideal measure” has led to advice such as “Increase font size for large screens and...
Read moreI should be incapable of drawing a single stroke at the present moment; and yet I feel that I never...
Read moreCopyright © 2024 freshnewstrademarket.com